var title_f38_44_39616="Proliferation extrapleural CT";
var content_f38_44_39616=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fatty proliferation of extrapleural fat after tuberculous pleurisy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fatty proliferation of the extrapleural fat between the parietal pleura and the endothoracic fascia as a sequel of previous tuberculous pleurisy. CT shows right posterior pleural thickening with a subjacent fatty layer. This likely results from the restriction of the lung and pulling of the chest wall fat inward.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39616=[""].join("\n");
var outline_f38_44_39616=null;
var title_f38_44_39617="AIDS-related Kaposis sarcoma - palate";
var content_f38_44_39617=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AIDS-related Kaposi's sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodules of Kaposi's sarcoma are present on the palate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39617=[""].join("\n");
var outline_f38_44_39617=null;
var title_f38_44_39618="Sacrocervicopexy complete";
var content_f38_44_39618=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sacrocervicopexy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 318px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After the suspension, the peritoneum is reapproximated over the mesh with either a running stitch of delayed absorbable suture,or interrupted sutures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter L Rosenblatt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39618=[""].join("\n");
var outline_f38_44_39618=null;
var title_f38_44_39619="Centruroides antivenom: Pediatric drug information";
var content_f38_44_39619=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Centruroides antivenom: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?21/50/22307?source=see_link\">",
"    see \"Centruroides antivenom: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/10/16547?source=see_link\">",
"    see \"Centruroides antivenom: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13215077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Anascorp&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F14181853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antivenin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F14181960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Scorpion envenomation:",
"     </b>",
"     I.V.: Initial: 3 vials (~&le;360 mg total protein and &ge;450 LD50 [mouse] neutralizing units) initiated  as soon as possible after scorpion sting; may administer additional vials in 1-vial increments every 30-60 minutes as needed",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F14181861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?21/50/22307?source=see_link\">",
"      see \"Centruroides antivenom: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Scorpion envenomation:",
"     </b>",
"     Infants, Children, Adolescents, and Adults: I.V.: Initial: 3 vials (~&le;360 mg total protein and &ge;450 LD50 [mouse] neutralizing units) initiated as soon as possible after scorpion sting; may administer additional vials in 1-vial increments every 30-60 minutes as needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     There are no dosage adjustments provided in manufacturer's labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     There are no dosage adjustments provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13168512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anascorp&reg;: &le;120 mg total protein and &ge;150 LD50 (mouse) neutralizing units [contains cresol, sucrose 4.3-38.3 mg/vial]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F14181862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Reconstitute each vial with 5 mL of NS; gently swirl to mix. Dilute dose (eg, 1-3 vials) with NS to a total volume of 50 mL. Administer over 10 minutes; others have reported beginning infusion slower at 25-50 mL/hour and then double the rate every 5 minutes as tolerated (Turri, 2011); monitor for return of symptoms of envenomation and repeat as needed. Medications (eg, epinephrine, corticosteroids, diphenhydramine) and equipment for resuscitation should be readily available in case of hypersensitivity reactions. I.M. administration should generally be avoided since the time to peak blood concentration may be prolonged with this route of administration (Turri, 2011; Vasquez, 2010). If unable to obtain intravenous access, intraosseous (full dose) and intramuscular (single vial dose) administration have been reported in a neonate and a 16 month old child (Hiller, 2010).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F13168384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F14181858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store unused vials at room temperature of 25&deg;C (77&deg;F); excursions permitted up to 40&deg;C (104&deg;F); do not freeze. Discard partially used vials. May further dilute in NS.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F14181854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of scorpion envenomation in patients with clinical signs of envenomation including, but not limited to, loss of muscle control, roving or abnormal eye movements, slurred speech, respiratory distress, excessive salivation, frothing at mouth, and vomiting (FDA approved in ages of neonates through adults)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F13168374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Fatigue, fever, headache, lethargy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Cough, rhinorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Aspiration, ataxia, chest tightness, eye edema, hypersensitivity, hypoxia, palpitation, pneumonia, respiratory distress, serum sickness (delayed)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F14263985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Hypersensitivity to",
"     <i>",
"      Centruroides",
"     </i>",
"     Immune F(ab&rsquo;)",
"     <sub>",
"      2",
"     </sub>",
"     (Equine) or any component",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F14181856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product derived from equine (horse) immune globulin F(ab&rsquo;)2 fragments; anaphylaxis and anaphylactoid reactions are possible, especially in patients with known allergies to horse protein. Patients who have had previous treatment with",
"     <i>",
"      Centruroides",
"     </i>",
"     immune F(ab&rsquo;)2 or other equine-derived antivenom/antitoxin may be at a higher risk for hypersensitivity reactions. In patients who develop an anaphylactic reaction, discontinue the infusion and administer emergency care. Immediate treatment (eg, epinephrine 1:1000, corticosteroids, diphenhydramine) should be available. Delayed serum sickness may occur, usually within 2 weeks; monitor patients with follow-up visits for signs and symptoms (eg, arthralgia, fever, myalgia, rash). Product of equine (horse) plasma; may potentially contain infectious agents (eg, viruses) which could transmit disease. May contain small amounts of cresol resulting from the manufacturing process; local reactions and myalgias may occur.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F13225889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13168366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13168367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F14181863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Signs and symptoms of envenomation (eg, opsoclonus, involuntary muscle movement, slurred speech, paresthesias, respiratory distress, salivation, frothy sputum, vomiting); signs and symptoms of hypersensitivity reactions; follow-up visits for signs and symptoms of serum sickness (eg, arthralgia, fever, myalgia, rash)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F14181859\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contains venom-specific F(ab&rsquo;)",
"     <sub>",
"      2",
"     </sub>",
"     fragments of IgG which bind and neutralize venom toxins; thereby helping to remove the toxin from the target tissue and eliminate it from the body.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F14181959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset: Time to resolution of symptoms: Children: 1.28 &plusmn; 0.8 hours; Adults: 1.91 &plusmn; 1.4 hours; &gt;95% of all patients will experience resolution of symptoms within 4 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F14181860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : 13.6 L &plusmn; 5.4 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life: 159 &plusmn; 57 hours",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F14181864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/10/16547?source=see_link\">",
"      see \"Centruroides antivenom: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Common side effects include nausea, vomiting, fever, rash, headaches, muscle pain, and pruritus. May cause hypersensitivity reactions; inform physician of horse protein sensitivity or have received treatment before with antivenom due to higher risk for reactions. Immediately notify physician for shortness of breath and/or itching. May cause delayed reactions (about 2 weeks following dose); notify prescriber if experience muscular or joint pain or rash after discharge.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F14181865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Each vial of",
"     <i>",
"      Centruroides",
"     </i>",
"     immune F(ab&rsquo;)",
"     <sub>",
"      2",
"     </sub>",
"     (equine) contains &le;120 mg total protein and &ge;150 LD50 (mouse) neutralizing units.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Boyer LV, Theodorou AA, Berg RA, et al, \"Antivenom for Critically Ill Children With Neurotoxicity From Scorpion Stings,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2009, 360(20):2090-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39619/abstract-text/19439743/pubmed\" id=\"19439743\" target=\"_blank\">",
"        19439743",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hiller K, Jarrod MM, Franke HA, et al, \"Scorpion Antivenom Administered by Alternative Infusions,\"",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2010, 56(3):309-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39619/abstract-text/20728778/pubmed\" id=\"20728778\" target=\"_blank\">",
"        20728778",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tuuri RE and Reynolds S, &ldquo;Scorpion Envenomation and Antivenom Therapy,&rdquo;",
"      <i>",
"       Pediatr Emerg Care",
"      </i>",
"      , 2011, 27(7):667-675.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39619/abstract-text/21730810/pubmed\" id=\"21730810\" target=\"_blank\">",
"        21730810",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vasquez H, Chavez-Haro A, Garcia-Ubbelohde W, et al, &ldquo;Pharmacokinetics of a F(ab&rsquo;)2 Scorpion Antivenom Administered Intramuscularly in Healthy Human Volunteers,&rdquo;",
"      <i>",
"       Int Immunopharmacol",
"      </i>",
"      , 2010, 10(11):1318-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39619/abstract-text/20849955/pubmed\" id=\"20849955\" target=\"_blank\">",
"        20849955",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83876 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-FDF33D9AD5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39619=[""].join("\n");
var outline_f38_44_39619=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13215077\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181853\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181960\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181861\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13168512\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181862\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13168384\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181858\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181854\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13168374\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14263985\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181856\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299002\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13225889\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13168366\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13168367\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181863\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181859\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181959\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181860\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181864\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14181865\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/83876\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/83876|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?21/50/22307?source=related_link\">",
"      Centruroides antivenom: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/10/16547?source=related_link\">",
"      Centruroides antivenom: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_44_39620="Benztropine: Patient drug information";
var content_f38_44_39620=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Benztropine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     see \"Benztropine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/45/36563?source=see_link\">",
"     see \"Benztropine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F140212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cogentin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F140213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Benztropine&reg;;",
"     </li>",
"     <li>",
"      Benztropine Omega;",
"     </li>",
"     <li>",
"      PMS-Benztropine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692011",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Parkinson's disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat side effects caused by some drugs used to treat schizophrenia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give to a child younger than 3 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man with problems passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11249 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-9F9DC17642-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39620=[""].join("\n");
var outline_f38_44_39620=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140212\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140213\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014666\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014665\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014670\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014671\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014673\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014668\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014669\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014674\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014675\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=related_link\">",
"      Benztropine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/45/36563?source=related_link\">",
"      Benztropine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_44_39621="Mixed flora on blood agar";
var content_f38_44_39621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66953&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66953&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Growth of mixed flora on blood agar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Expectorated sputum showing different colonial morphologies on blood agar which represents mixed flora; this result is common even in the absence of a bacterial lower tract respiratory infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Melvin P Weinstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39621=[""].join("\n");
var outline_f38_44_39621=null;
var title_f38_44_39622="Valacyclovir: Drug information";
var content_f38_44_39622=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Valacyclovir: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/45/35540?source=see_link\">",
"    see \"Valacyclovir: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/35/3638?source=see_link\">",
"    see \"Valacyclovir: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F232799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Valtrex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F232800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Valacyclovir&reg;;",
"     </li>",
"     <li>",
"      CO Valacyclovir;",
"     </li>",
"     <li>",
"      DOM-Valacyclovir;",
"     </li>",
"     <li>",
"      Mylan-Valacyclovir;",
"     </li>",
"     <li>",
"      PHL-Valacyclovir;",
"     </li>",
"     <li>",
"      PMS-Valacyclovir;",
"     </li>",
"     <li>",
"      PRO-Valacyclovir;",
"     </li>",
"     <li>",
"      Riva-Valacyclovir;",
"     </li>",
"     <li>",
"      Valtrex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F232819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiviral Agent;",
"     </li>",
"     <li>",
"      Antiviral Agent, Oral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F232803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      CMV prophylaxis in allogeneic HSCT recipients (unlabeled use):",
"     </b>",
"     2 g 4 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Herpes labialis (cold sores):",
"     </b>",
"     Oral: 2 g twice daily for 1 day (separate doses by ~12 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Herpes zoster (shingles):",
"     </b>",
"     Oral: 1 g 3 times daily for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      HSV, VZV in cancer patients (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Prophylaxis:",
"     </i>",
"     500 mg 2-3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Treatment:",
"     </i>",
"     1 g 3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Genital herpes:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Initial episode:",
"     </i>",
"     1 g twice daily for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Recurrent episode:",
"     </i>",
"     500 mg twice daily for 3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Reduction of transmission:",
"     </i>",
"     500 mg once daily (source partner)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Suppressive therapy:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Immunocompetent patients: 1 g once daily (500 mg once daily in patients with &lt;9 recurrences per year)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     HIV-infected patients (CD4 &ge;100 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ): 500 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F232813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/35/3638?source=see_link\">",
"      see \"Valacyclovir: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chickenpox:",
"     </b>",
"     Children 2 to &lt;18 years: 20 mg/kg/dose 3 times daily for 5 days (maximum: 1 g 3 times daily)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Herpes labialis (cold sores):",
"     </b>",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F232804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F232805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Herpes zoster:",
"      </i>",
"     </b>",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      U.S. labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-49 mL/minute: 1 g every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: 1 g every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;30 mL/minute: No dosage adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-30 mL/minute: 1 g every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute: 1 g every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Genital herpes:",
"      </i>",
"     </b>",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      U.S. labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial episode:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: 1 g every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Recurrent episode: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;29 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Suppressive therapy: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;29 mL/minute:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     For usual dose of 1 g every 24 hours, decrease dose to 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     For usual dose of 500 mg every 24 hours, decrease dose to 500 mg every 48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     HIV-infected patients: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial episode:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-30 mL/minute: 1 g every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Recurrent episode:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-30 mL/minute: 500 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Suppressive therapy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-30 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Immunocompetent or HIV-infected patients: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Immunocompetent patients and &le;9 recurrences/year: 500 mg every 48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Herpes labialis:",
"      </i>",
"     </b>",
"     Adolescents and Adults",
"     <i>",
"      (U.S. labeling)",
"     </i>",
"     or Adults",
"     <i>",
"      (Canadian labeling)",
"     </i>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-49 mL/minute: 1 g every 12 hours for 2 doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: 500 mg every 12 hours for 2 doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: 500 mg as a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hemodialysis: Dialyzable (~33% removed during 4-hour session); administer dose postdialysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Chronic ambulatory peritoneal dialysis/continuous arteriovenous hemofiltration dialysis: Pharmacokinetic parameters are similar to those in patients with ESRD; supplemental dose not needed following dialysis",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F5702788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment required.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F232774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral: 500 mg, 1 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Valtrex&reg;: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Valtrex&reg;: 1 g [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 500 mg, 1 g",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F232759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F232778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     If GI upset occurs, administer with meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F232777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of herpes zoster (shingles) in immunocompetent patients; treatment of first-episode and recurrent genital herpes; suppression of recurrent genital herpes and reduction of transmission of genital herpes in immunocompetent patients; suppression of genital herpes in HIV-infected individuals; treatment of herpes labialis (cold sores); chickenpox in immunocompetent children",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F5699359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis of cancer-related HSV, VZV, and CMV infections; treatment of cancer-related HSV, VZV infection",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F232826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Valtrex&reg; may be confused with Keflex&reg;, Valcyte&reg;, Zovirax&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ValACYclovir may be confused with acyclovir, valGANciclovir, vancomycin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F232817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (13% to 38%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (5% to 15%), abdominal pain (1% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Neutropenia (&le;18%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: ALT increased (&le;14%), AST increased (2% to 16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Nasopharyngitis (&le;16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue (&le;8%), depression (&le;7%), fever (children 4%), dizziness (2% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (&le;8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine: Dysmenorrhea (&le;1% to 8%), dehydration (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (&lt;1% to 6%), diarrhea (children 5%; adults &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Thrombocytopenia (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased (&le;4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (&lt;1 to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinorrhea (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Herpes simplex (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Acute hypersensitivity reactions (angioedema, anaphylaxis, dyspnea, pruritus, rash, urticaria); aggression, agitation, alopecia, anemia, aplastic anemia, ataxia, creatinine increased, coma, confusion, consciousness decreased, delirium, dysarthria, encephalopathy, erythema multiforme, facial edema, hallucinations (auditory and visual), hemolytic uremic syndrome (HUS), hepatitis, hypertension, leukocytoclastic vasculitis, leukopenia, mania, photosensitivity reaction, psychosis, renal failure, renal pain, seizure, tachycardia, thrombotic thrombocytopenic purpura (TTP), tremor, urinary precipitation, visual disturbances",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F232781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to valacyclovir, acyclovir, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F232763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: CNS adverse effects (including agitation, hallucinations, confusion, delirium, seizures, and encephalopathy) have been reported in both adult and pediatric patients with or without  renal dysfunction. Elderly patients are more likely to experience CNS adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: Has occurred in immunocompromised patients (at doses of 8 g/day).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Urinary precipitation: Decreased precipitation in renal tubules may occur; adequately hydrate patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use caution in patients with renal impairment, the elderly, and/or those receiving nephrotoxic agents. Acute renal failure and CNS effects have been observed in patients with renal dysfunction; dose adjustment may be required. Precipitation in renal tubules may occur; maintain adequate hydration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; CNS effects have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunocompromised patients: Advanced HIV (CD4 &lt;100 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ): Safety and efficacy have not been established for treatment/suppression of recurrent genital herpes or disseminated herpes in patients with profound immunosuppression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in patients &lt;2 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For cold sores, treatment should begin with earliest symptom (tingling, itching, burning). For genital herpes, treatment should begin as soon as possible after the first signs and symptoms (within 72 hours of onset of first diagnosis or within 24 hours of onset of recurrent episodes). For herpes zoster, treatment should begin within 72 hours of onset of rash. For chickenpox, treatment should begin with earliest sign or symptom.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F232768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: May increase the serum concentration of Acyclovir-Valacyclovir. Acyclovir-Valacyclovir may increase the serum concentration of Mycophenolate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tenofovir: Acyclovir-Valacyclovir may decrease the excretion of Tenofovir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zidovudine: Acyclovir-Valacyclovir may enhance the CNS depressant effect of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zoster Vaccine: Acyclovir-Valacyclovir may diminish the therapeutic effect of Zoster Vaccine.  Management: When possible, discontinue antiviral agents with anti-zoster activity (i.e., acyclovir, valacyclovir, famciclovir) for at least 24 hours prior to and 14 days after receiving a live attenuated zoster vaccine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F232770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F232784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic events were not observed in animal studies. Data from a pregnancy registry has shown no increased rate of birth defects than that of the general population; however, the registry is small and use during pregnancy is only warranted if the potential benefit to the mother justifies the risk of the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F232809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F232785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Peak concentrations in breast milk range from 0.5-2.3 times the corresponding maternal acyclovir serum concentration. This is expected to provide a nursing infant with a dose of acyclovir equivalent to ~0.6 mg/kg/day following ingestion of valacyclovir 500 mg twice daily by the mother. Use with caution while breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F232786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F232783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (ValACYclovir HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (30): $379.26",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (30): $216.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Valtrex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (30): $421.87",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (90): $723.14",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F232772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urinalysis, BUN, serum creatinine, liver enzymes, and CBC",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F232787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Herclov (ID);",
"     </li>",
"     <li>",
"      Inclovir (ID);",
"     </li>",
"     <li>",
"      Rapivir (MX, UY);",
"     </li>",
"     <li>",
"      Talavir (IT);",
"     </li>",
"     <li>",
"      Vacyless (TW);",
"     </li>",
"     <li>",
"      Vadiral (CO);",
"     </li>",
"     <li>",
"      Valcivir (IN);",
"     </li>",
"     <li>",
"      Valcyclor (CO);",
"     </li>",
"     <li>",
"      Valraci (KP);",
"     </li>",
"     <li>",
"      Valtcro (KP);",
"     </li>",
"     <li>",
"      Valtra (KP);",
"     </li>",
"     <li>",
"      Valtrex (AE, AR, AT, AU, BB, BD, BG, BH, BM, BR, BS, BZ, CH, CL, CN, CO, CR, CY, CZ, DE, DO, EC, EE, EG, ES, FI, GB, GR, GT, GY, HK, HN, ID, IE, IL, IQ, IR, JM, JO, JP, KP, KW, LB, LY, MY, NI, NO, NZ, OM, PA, PH, PK, PL, PR, PT, PY, QA, RU, SA, SE, SG, SR, SV, SY, TH, TR, TT, TW, VE, YE);",
"     </li>",
"     <li>",
"      Valvir (ID);",
"     </li>",
"     <li>",
"      Viranet (AR);",
"     </li>",
"     <li>",
"      Zelitrex (BE, DK, FR, NL);",
"     </li>",
"     <li>",
"      Zosvir (EC)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F232762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Valacyclovir is rapidly and nearly completely converted to acyclovir by intestinal and hepatic metabolism. Acyclovir is converted to acyclovir monophosphate by virus-specific thymidine kinase then further converted to acyclovir triphosphate by other cellular enzymes. Acyclovir triphosphate inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate for viral DNA polymerase and being incorporated into viral DNA.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F232780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Acyclovir is widely distributed throughout the body including brain, kidney, lungs, liver, spleen, muscle, uterus, vagina, and CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~14% to 18%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; valacyclovir is rapidly and nearly completely converted to acyclovir and L-valine by first-pass effect; acyclovir is hepatically metabolized to a very small extent by aldehyde oxidase and by alcohol and aldehyde dehydrogenase (inactive metabolites)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~55% once converted to acyclovir",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Normal renal function: Adults: Acyclovir: 2.5-3.3 hours, Valacyclovir: ~30 minutes; End-stage renal disease: Acyclovir: 14-20 hours; During hemodialysis: 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine, primarily as acyclovir (89%);",
"     <b>",
"      Note:",
"     </b>",
"     Following oral administration of radiolabeled valacyclovir, 46% of the label is eliminated in the feces (corresponding to nonabsorbed drug), while 47% of the radiolabel is eliminated in the urine.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Acosta EP and Fletcher CV, &ldquo;Valacyclovir,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1997, 31(2):185-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9034421/pubmed\" id=\"9034421\" target=\"_blank\">",
"        9034421",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Alrabiah FA and Sacks SL, &ldquo;New Antiherpesvirus Agents. Their Targets and Therapeutic Potential,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1996, 52(1):17-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/8799682/pubmed\" id=\"8799682\" target=\"_blank\">",
"        8799682",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Beutner KR, Friedman DJ, Forszpaniak C, et al, &ldquo;Valacyclovir Compared With Acyclovir for Improved Therapy for Herpes Zoster in Immunocompetent Adults,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1995, 39(7):1546-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/7492102/pubmed\" id=\"7492102\" target=\"_blank\">",
"        7492102",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bodsworth NJ, Crooks RJ, Borelli S, et al, &ldquo;Valaciclovir Versus Aciclovir in Patients Initiated Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind Clinical Trial. International Valaciclovir HSV Study Group,&rdquo;",
"      <i>",
"       Genitourin Med",
"      </i>",
"      , 1997, 73(2):110-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9215092/pubmed\" id=\"9215092\" target=\"_blank\">",
"        9215092",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grant DM, Mauskopf JA, Bell L, et al, &ldquo;Comparison of Valaciclovir and Acyclovir for the Treatment of Herpes Zoster in Immunocompetent Patients Over 50 Years of Age: A Cost-Consequence Model,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1997, 17(2):333-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9085325/pubmed\" id=\"9085325\" target=\"_blank\">",
"        9085325",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Prevention and Treatment of Cancer-Related Infections,&rdquo; Version 1.2008. Available at  file://www.nccn.org/professionals/physician_gls/PDF/infections.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Patel R, Bodsworth NJ, Woolley P, et al, &ldquo;Valaciclovir for the Suppression of Recurrent Genital HSV Infection: A Placebo Controlled Study of Once Daily Therapy. International Valaciclovir HSV Study Group,&rdquo;",
"      <i>",
"       Genitourin Med",
"      </i>",
"      , 1997, 73(2):105-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9215091/pubmed\" id=\"9215091\" target=\"_blank\">",
"        9215091",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perry CM and Faulds D, &ldquo;Valaciclovir. A Review of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in Herpesvirus Infections,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1996, 52(5):754-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9118821/pubmed\" id=\"9118821\" target=\"_blank\">",
"        9118821",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Public Health Agency of Canada, &ldquo;Canadian Guidelines on Sexually Transmitted Infections.\" Available at file://www.phac-aspc.gc.ca/std-mts/sti-its/guide-lignesdir-eng.php. Accessed August 9, 2012.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reitano M, Tyring S, Lang W, et al, &ldquo;Valaciclovir for the Suppression of Recurrent Genital Herpes Simplex Virus Infection: A Large-Scale Dose Range-Finding Study. International Valaciclovir HSV Study Group,&rdquo;",
"      <i>",
"       J Infect Dis",
"      </i>",
"      , 1998, 178(3):603-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9728526/pubmed\" id=\"9728526\" target=\"_blank\">",
"        9728526",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tyring SK, Douglas JM Jr, Corey L, et al, &ldquo;A Randomized, Placebo-Controlled Comparison of Oval Valacyclovir and Acyclovir in Immunocompetent Patients With Recurrent Genital Herpes Infections. The Valaciclovir International Study Group,&rdquo;",
"      <i>",
"       Arch Dermatol",
"      </i>",
"      , 1998, 134(2):185-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/9487210/pubmed\" id=\"9487210\" target=\"_blank\">",
"        9487210",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Valacyclovir,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 1996, 38(965):3-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/8551979/pubmed\" id=\"8551979\" target=\"_blank\">",
"        8551979",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weller S, Blum MR, Doucette M, et al, &ldquo;Pharmacokinetics of the Acyclovir Prodrug Valaciclovir After Escalating Single- and Multiple-Dose Administration to Normal Volunteers,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1993, 54(6):595-605.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/44/39622/abstract-text/8275615/pubmed\" id=\"8275615\" target=\"_blank\">",
"        8275615",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10034 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39622=[""].join("\n");
var outline_f38_44_39622=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232799\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232800\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232819\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232803\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232813\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232804\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232805\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5702788\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232774\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232759\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232778\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232777\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5699359\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232826\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232817\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232781\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232763\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300201\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232768\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232770\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232784\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232809\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232785\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232786\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232783\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232772\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232787\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232762\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232780\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10034\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10034|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/45/35540?source=related_link\">",
"      Valacyclovir: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/35/3638?source=related_link\">",
"      Valacyclovir: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_44_39623="Techniques and interpretation of HIV-1 RNA quantitation";
var content_f38_44_39623=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Techniques and interpretation of HIV-1 RNA quantitation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/44/39623/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/44/39623/contributors\">",
"     Angela M Caliendo, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/44/39623/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/44/39623/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/44/39623/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/44/39623/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/44/39623/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human immunodeficiency virus type 1 (HIV-1) RNA quantification or viral load measurements are routinely used in the management of persons infected with HIV-1.",
"   </p>",
"   <p>",
"    This topic will address the methods used for HIV RNA detection and the use of viral load testing in clinical management. Information on the use of immunologic markers, such as CD4 cell counts, is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/52/21320?source=see_link\">",
"     \"Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14118660\">",
"    <span class=\"h1\">",
"     IMPORTANCE OF HIV VIRAL LOAD MEASUREMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have shown HIV-1 RNA levels to be a predictor of the time to progression to acquired immunodeficiency syndrome (AIDS) and death that is independent of CD4 cell counts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Viral load measurements are also useful in determining when to initiate antiretroviral therapy, and in monitoring the response to such therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    .) In specific situations (neonatal infection and acute infection), HIV-1 RNA levels also may be useful in establishing the diagnosis of HIV infection, but HIV antibody tests are primarily used for this purpose. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LABORATORY METHODS FOR QUANTITATION OF HIV-1 RNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are five commercial assays that have been approved by the United States Food and Drug Administration (FDA) to quantify HIV-1 RNA from plasma samples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The AMPLICOR HIV Monitor Test (Roche Diagnostics) is a conventional reverse transcriptase polymerase chain reaction (RT-PCR) assay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/12\">",
"       12",
"      </a>",
"      ] (standard and ultrasensitive)",
"     </li>",
"     <li>",
"      Versant HIV-1 RNA 3.0 assay (Bayer Diagnostics) is a branched DNA (bDNA) assay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The NucliSens HIV RNA QT (BioMereiux) is a nucleic acid sequence based amplification (NASBA) assay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The COBAS",
"      <span class=\"nowrap\">",
"       AmpliPrep/COBAS",
"      </span>",
"      TaqMan HIV-1 Test (Roche Diagnostics) is a real-time RT-PCR assay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The RealTime HIV-1 (Abbott Molecular) is a real-time RT-PCR assay.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The newer real-time RT-PCR assays offer several advantages: They are very sensitive (40 to 50",
"    <span class=\"nowrap\">",
"     copies/mL)",
"    </span>",
"    with a broad linear range (6 log",
"    <sub>",
"     10",
"    </sub>",
"    ), and they pose a lower risk of carry over contamination than standard PCR assays. Studies of the two real-time RT-PCR tests have shown comparable viral load values between the two tests for Group M viruses, although the viral load values for circulating recombinant forms (CRFs) may be lower for the COBAS",
"    <span class=\"nowrap\">",
"     AmpliPrep/COBAS",
"    </span>",
"    TaqMan (COBAS TaqMan) compared with the RealTime HIV-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. One study comparing the COBAS TaqMan assay with the Amplicor Monitor assay showed HIV-1 RNA values to be slightly lower with the COBAS TaqMan assay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/19\">",
"     19",
"    </a>",
"    ], while another study showed viral load values to be significantly lower with COBAS TaqMan assay compared with the Amplicor Monitor test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The correlation between the plasma HIV-1 RNA measurements obtained with the bDNA, Amplicor Monitor and NucliSens assays is approximately 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/6,21,22\">",
"     6,21,22",
"    </a>",
"    ]. In a small study comparing the quantification of HIV-1 RNA using the NASBA and RT-PCR assays, most patients were found to have comparable viral load levels with both methods; however, for some patients the difference in HIV-1 RNA levels between the two assays was more than 0.5 log",
"    <sub>",
"     10",
"    </sub>",
"    (threefold) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/23\">",
"     23",
"    </a>",
"    ]. Discrepancies are more predictable when plasma samples are tested by bDNA and RT-PCR: the concentration of HIV-1 RNA obtained with RT-PCR is approximately twofold higher than that obtained with bDNA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/6\">",
"     6",
"    </a>",
"    ]. The viral load levels obtained with the bDNA (version 3.0) and the AMPLICOR RT-PCR assay (version 1.5) were highly correlated in one study; differences between the two assays were within the coefficients of variation for the assays [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, it is important to use the same assay when following HIV-1 RNA levels over time. Ideally, if the viral load assay used to monitor patients is changed, a new baseline viral load measurement should be obtained.",
"   </p>",
"   <p>",
"    There also may be differences in viral load measurements between men and women; one study of 812 specimens from 650 injection drug users (IDU) showed that women had lower viral copies compared with men controlling for CD4 counts (3365",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    versus 8907 by bDNA and 45,416",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    versus 93,130 by RT-PCR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/25\">",
"     25",
"    </a>",
"    ]. The time to the development of AIDS was not different for the sexes in this natural history cohort study initiated in 1988 to 1989, raising the question of whether women develop AIDS at a lower viral load threshold than men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Specimen collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The RT-PCR and bDNA assays have been designed to measure HIV-1 RNA from plasma specimens. The NASBA assay uses a unique nucleic acid extraction method that removes substances that may inhibit amplification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/26\">",
"     26",
"    </a>",
"    ]. This allows the assay to accommodate a wide range of clinical specimens including plasma, cerebrospinal fluid (CSF), blood, cells, semen, and cervical secretions. Finger prick samples have also been tested in the Abbott RealTime test, and due to reduced sample volume the test had a lower limit of quantification of approximately 500",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For routine clinical use, viral load measurements are performed on plasma specimens. The blood should ideally be anticoagulated in EDTA (purple top tube), since the virus is most stable in this anticoagulant. Acid citrate dextrose (ACD) can also be used as an anticoagulant, but there may be a 15 percent decrease in the viral load measurement due to the volume of the anticoagulant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Blood anticoagulated in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is unacceptable for the RT-PCR and bDNA assays. Any anticoagulant is acceptable for the NASBA assay.",
"   </p>",
"   <p>",
"    Due to the instability of HIV-1 RNA in whole blood, it is critical to handle clinical specimens properly to minimize the risk of RNA degradation. Plasma should be separated within six hours of collection and ideally stored at -20&ordm;C, although plasma viral RNA is stable at 4&ordm;C for several days. Failure to separate plasma promptly may lead to degradation of viral RNA and a falsely decreased viral load measurement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In addition, viral load measurements may be reduced by as much as 50 percent if serum samples are used, probably due to trapping of the viral particles in the clot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/29\">",
"     29",
"    </a>",
"    ]. For this reason, plasma specimens should be used when viral load measurements are followed over time.",
"   </p>",
"   <p>",
"    The standard RT-PCR assay requires 200 microL of plasma, the ultrasensitive RT-PCR assay requires 500 microL of plasma, and the bDNA assay requires 1 mL of plasma. A specimen volume of between 100 microL and 2 mL can be used in the NASBA assay, although the standard volume is 1 mL. The real-time PCR tests require between 0.5 and 1.0 mL of plasma.",
"   </p>",
"   <p>",
"    Plasma preparation tubes (PPTs) contain a gel barrier that physically separates plasma from the cellular components, and have an advantage in that whole blood can be collected in these tubes and held at room temperature for up to six hours prior to centrifugation and shipped in their original tube at ambient temperature without affecting the viral load values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/30\">",
"     30",
"    </a>",
"    ]. However, after centrifugation, PPTs should either be stored refrigerated or plasma should be removed from PPTs prior to freezing, as freezing the plasma samples in PPTs can falsely elevate the viral load values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Quantification and linear range",
"    </span>",
"    &nbsp;&mdash;&nbsp;The available assays differ in their limit of quantification and linear range. The lower limit of quantification is a key characteristic of viral load assays, and how this parameter is defined is equally important. As an example, the NucliSens NASBA assay can detect as few as 20",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    when one milliliter of plasma is used, but this level is detected in fewer than 50 percent of replicates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/33\">",
"     33",
"    </a>",
"    ]. The limit of quantification is best defined as the amount of nucleic acid that can be verified in 95 percent of replicate samples. Using this definition, the limit of quantification and linear range of the assays is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ultrasensitive AMPLICOR RT-PCR assay (version 1.5) &ndash; 50 to 100,000",
"      <span class=\"nowrap\">",
"       copies/mL;",
"      </span>",
"      standard AMPLICOR RT-PCR assay (version 1.5) &ndash; 400 to 750,000",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The Versant bDNA assay &ndash; 75 to 500,000",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/34\">",
"       34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The NASBA assay &ndash; 176 to 3.4 million",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/33,36\">",
"       33,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The COBAS",
"      <span class=\"nowrap\">",
"       AmpliPrep/COBAS",
"      </span>",
"      TaqMan version 1 HIV-1 test &ndash; 48 to 10 million",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"     </li>",
"     <li>",
"      The COBAS",
"      <span class=\"nowrap\">",
"       AmpliPrep/COBAS",
"      </span>",
"      TaqMan version 2 HIV-1 test &ndash; 20 to 10 million",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"     </li>",
"     <li>",
"      The RealTime HIV-1 &ndash; 40 to 10 million",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnostic testing in adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;The RT-PCR, bDNA, and NASBA assays have been designed to measure HIV-1 RNA in plasma from patients known to be infected with HIV-1. They have not been approved for use as diagnostic tests; as noted above, ELISA and Western blot tests that measure HIV-1 antibody should be used for this purpose. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the serologic diagnosis of acute HIV-1 infection can be difficult when a patient is in the \"window period\", after exposure but before seroconversion. In this setting, the ELISA and Western blot tests will be negative or indeterminate, while viral RNA assays will be positive because plasma viral RNA levels are very high in patients with acute HIV-1 infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/28/31175?source=see_link&amp;anchor=H7#H7\">",
"     \"Transfusion transmitted HIV infection and AIDS\", section on 'Defining the HIV window period'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At present, there are no controlled trials studying the sensitivity and specificity of viral RNA assays as diagnostic tests in adults with acute HIV-1 infection. Although viral load tests have proven to be useful in the diagnosis of acute HIV-1 infection, there have been reports of false positive results, mostly occurring with the bDNA assay in the low range of the assay (below 2,000",
"    <span class=\"nowrap\">",
"     copies/mL).",
"    </span>",
"    The viral load in patients with acute HIV-1 infection is highly variable, ranging in one prospective series of 74 patients from 27,200 to 1.6 million copies per mL of plasma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/39\">",
"     39",
"    </a>",
"    ]. However, most patients with acute infection have a viral load of &gt;100,000",
"    <span class=\"nowrap\">",
"     copies/mL.",
"    </span>",
"    There is qualitative HIV-1 RNA assay, the APTIMA&reg; HIV-1 Qualitative assay (GenProbe), that has been approved for the diagnosis of HIV-1, including acute infection. The assay uses transcription mediated amplification technology to amplify and detect LTR and pol gene sequences of the HIV-1 genome; the assay detects all group M subtypes and groups N and O.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnostic testing in neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonates with possible HIV infection represent a special circumstance since IgG antibodies cross the placenta. The use of HIV-1 DNA and RNA assays for diagnosis of neonatal HIV infection is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/44/35525?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnostic testing for HIV infection in infants and children younger than 18 months\", section on 'Diagnostic tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INTERPRETATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several issues that must be considered when interpreting the results of HIV-1 RNA measurements. These include the clinical significance of changes in viral load, the relationship of HIV-1 RNA to the CD4 cell count, and the possible presence of HIV-1 subtypes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinically significant changes in viral load",
"    </span>",
"    &nbsp;&mdash;&nbsp;To determine if changes in viral load represent clinically significant changes in viral replication both intra-assay and biologic variation need to be considered. Each of the viral load assays has a low intra-assay variation, between 0.12 and 0.2 log",
"    <sub>",
"     10",
"    </sub>",
"    , on repeated testing of a single specimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/16,21,22,40\">",
"     16,21,22,40",
"    </a>",
"    ]. In general there is greater variability in the tests near the lower limit of detection. In clinically stable patients, HIV-1 RNA levels are relatively stable from week to week and month to month, providing antiretroviral therapy has not been initiated or changed. The biologic variability of viral RNA measurements is about 0.3 log",
"    <sub>",
"     10",
"    </sub>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/7\">",
"     7",
"    </a>",
"    ]. A comprehensive evaluation of the AMPLICOR RT-PCR version 1.0 assay showed that the total variation was approximately 0.26 log",
"    <sub>",
"     10",
"    </sub>",
"    <span class=\"nowrap\">",
"     copies/mL,",
"    </span>",
"    which included intra-assay, inter-assay, and biologic variation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These data taken together have led to the recommendation that changes in HIV-1 RNA levels must exceed at least 0.5 log",
"    <sub>",
"     10",
"    </sub>",
"    or threefold in magnitude to represent biologically relevant changes in viral replication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. It is important not to overinterpret small increases or decreases in viral RNA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14118983\">",
"    <span class=\"h2\">",
"     Exogenous factors that may affect HIV RNA levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral RNA levels can transiently rise during acute illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/42\">",
"     42",
"    </a>",
"    ], an outbreak of herpes simplex infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/43\">",
"     43",
"    </a>",
"    ], or vaccination against a variety of pathogens including influenza, pneumococcus, and tetanus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. The increases may be quite dramatic, 1 log",
"    <sub>",
"     10",
"    </sub>",
"    (tenfold) or greater; however, values usually return to baseline within one month. Thus, plasma HIV-1 RNA levels should not be measured within one month of any of these events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Relationship of HIV-1 RNA to CD4 cell count",
"    </span>",
"    &nbsp;&mdash;&nbsp;CD4 cell counts are correlated with viral RNA measurements, although the association is weak. In general, the higher the CD4 cell count the lower the viral RNA. However, for any given CD4 cell count there may be a 3 log",
"    <sub>",
"     10",
"    </sub>",
"    (1000-fold) range in viral RNA measurements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. As an example, patients with a CD4 cell count of 200",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    may have HIV-1 RNA levels ranging from 1000 to 100,000",
"    <span class=\"nowrap\">",
"     copies/mL.",
"    </span>",
"   </p>",
"   <p>",
"    As",
"    a result, viral RNA measurements should",
"    <strong>",
"     not",
"    </strong>",
"    replace CD4 cell counts in the management of HIV-1 infected patients; rather, the two parameters should be used in parallel. CD4 cell counts are very useful in determining when to initiate antiretroviral treatment and prophylactic therapy for opportunistic infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/52/21320?source=see_link\">",
"     \"Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     HIV-1 subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-1 is a genetically diverse virus that has been classified into three groups based upon significant differences in the sequence of the gag and envelope genes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Group M refers to the major group",
"     </li>",
"     <li>",
"      Group O refers to the outliers or outgroup",
"     </li>",
"     <li>",
"      Group N refers to non-M, non-O",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Group M is further divided into nine subtypes, referred to as subtypes A through D, F, through H, J, K. The geographic distribution of the subtypes varies. The most common subtype in North America and Europe is subtype B; in the United States, strains other than subtype B are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/46\">",
"     46",
"    </a>",
"    ], although there are reports of increasing genetic diversity of HIV-1 within the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Other subtypes, in particular A, C, D, and E, are commonly found in Africa and Asia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most commercial assays were initially developed and evaluated for samples containing subtype B. The HIV-1 RNA assays have variable accuracy in the detection of other HIV-1 subtypes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The bDNA assay accurately quantifies HIV-1 RNA from group M subtypes A through G [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/49\">",
"       49",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The NASBA assay accurately quantifies all group M subtypes of HIV-1 with the possible exception of subtype G [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/46,49\">",
"       46,49",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The AMPLICOR RT-PCR version 1.5 assay accurately quantifies group M subtypes A through H [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/11,49,50\">",
"       11,49,50",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The COBAS",
"      <span class=\"nowrap\">",
"       AmpliPrep/COBAS",
"      </span>",
"      TaqMan version 1 HIV-1 test accurately quantifies all group M and group N, and many recombinants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/17,19\">",
"       17,19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The COBAS",
"      <span class=\"nowrap\">",
"       AmpliPrep/COBAS",
"      </span>",
"      TaqMan version 2 HIV-1 test accurately quantifies all group M subtypes, group N, group O and many recombinants",
"     </li>",
"     <li>",
"      The RealTime HIV-1 test accurately quantifies all group M subtypes, group N, group O, and recombinants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/17,51\">",
"       17,51",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One study that compared various commercial assays with a second generation long terminal repeat-based PCR test demonstrated a high degree of correlation using samples that were genomically and geographically diverse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/52\">",
"     52",
"    </a>",
"    ]. Any degree of discrepancy that was noted between assays was not associated with a specific subtype, but rather with the degree of genomic diversity within the subtype. Of the currently available viral load tests, the RealTime HIV-1 test is the one that can detect group O virus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     GUIDELINES FOR THE USE OF HIV-1 RNA LEVELS IN CLINICAL PRACTICE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines for the use of HIV-1 RNA measurements in clinical practice are continually updated on the web at",
"    <a class=\"external\" href=\"file://aidsinfo.nih.gov/guidelines/default.aspx?menuitem=guidelines\">",
"     file://aidsinfo.nih.gov/Guidelines/Default.aspx?MenuItem=Guidelines",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39623/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of HIV RNA levels in the diagnosis of acute HIV infection and in guiding response to therapy in chronic infection are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22808?source=see_link\">",
"     \"Acute and early HIV infection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     AVAILABILITY AND COST OF VIRAL LOAD TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-1 RNA measurements are widely available in clinical microbiology and reference laboratories. The cost of the assay varies from $80 to $240 per test. Cost should not be the only factor in determining where to have the testing performed; viral load assays are complex and should be performed by experienced laboratories. There are a variety of proficiency tests available to assist in assessing the performance of laboratories.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14118823\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Human immunodeficiency virus type 1 (HIV-1) RNA quantification (eg, viral load testing) is routinely used in the management of persons infected with HIV-1. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some studies have shown HIV-1 RNA levels to be a predictor of the time to progression to AIDS and death, independent of CD4 cell counts. Viral load measurements are also useful in determining the response to antiretroviral therapy. (See",
"      <a class=\"local\" href=\"#H14118660\">",
"       'Importance of HIV viral load measurements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two main detection methods used for HIV RNA quantifications: real time polymerase chain reaction and branched chain DNA technology. For routine clinical use, viral load measurements are performed on plasma specimens, while research specimens may include cerebral spinal fluid, cervical fluid, or semen specimens. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Laboratory methods for quantitation of HIV-1 RNA'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who are not taking antiretroviral therapy, there are small fluctuations of viral load that may be seen which are clinically insignificant. Changes in HIV-1 RNA levels must exceed at least 0.5 log",
"      <sub>",
"       10",
"      </sub>",
"      (or a threefold change in magnitude) to represent biologically relevant changes in viral replication. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinically significant changes in viral load'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viral RNA levels can transiently rise during acute illness, an outbreak of herpes simplex infection, or after immunization. Thus, plasma HIV-1 RNA levels should not be measured within one month of any of these events. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinically significant changes in viral load'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CD4 cell counts are correlated with viral RNA measurements, although the association is weak. In general, the higher the CD4 cell count, the lower the viral RNA level. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Relationship of HIV-1 RNA to CD4 cell count'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/1\">",
"      Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/2\">",
"      O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996; 276:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/3\">",
"      O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996; 334:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/4\">",
"      Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med 1996; 335:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/5\">",
"      Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997; 336:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/6\">",
"      Mellors JW, Mu&ntilde;oz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/7\">",
"      Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med 1996; 2:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/8\">",
"      Hughes MD, Johnson VA, Hirsch MS, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med 1997; 126:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/9\">",
"      O'Brien WA, Hartigan PM, Daar ES, et al. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 1997; 126:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/10\">",
"      Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004; 292:251.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: file://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&amp;Search=Off&amp;GuidelineID=7&amp;ClassID=1 (Accessed on April 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/12\">",
"      Mulder J, McKinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994; 32:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/13\">",
"      Pachl C, Todd JA, Kern DG, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/14\">",
"      van Gemen B, Kievits T, Nara P, et al. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS 1993; 7 Suppl 2:S107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/15\">",
"      van Gemen B, van Beuningen R, Nabbe A, et al. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods 1994; 49:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/16\">",
"      Schumacher W, Frick E, Kauselmann M, et al. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 2007; 38:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/17\">",
"      Gueudin M, Plantier JC, Lem&eacute;e V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007; 44:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/18\">",
"      Foulongne V, Montes B, Didelot-Rousseau MN, Segondy M. Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma. J Clin Microbiol 2006; 44:2963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/19\">",
"      Berger A, Scherzed L, St&uuml;rmer M, et al. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. J Clin Virol 2005; 33:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/20\">",
"      Damond F, Roquebert B, B&eacute;nard A, et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J Clin Microbiol 2007; 45:3436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/21\">",
"      Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses 1995; 11:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/22\">",
"      Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994; 170:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/23\">",
"      Vandamme AM, Schmit JC, Van Dooren S, et al. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/24\">",
"      Elbeik T, Charlebois E, Nassos P, et al. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol 2000; 38:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/25\">",
"      Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/26\">",
"      Boom R, Sol CJ, Salimans MM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/27\">",
"      Jain V, Liegler T, Kabami J, et al. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. Clin Infect Dis 2013; 56:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/28\">",
"      Dickover RE, Herman SA, Saddiq K, et al. Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J Clin Microbiol 1998; 36:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/29\">",
"      Holodniy M, Mole L, Yen-Lieberman B, et al. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol 1995; 33:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/30\">",
"      Holodniy M, Rainen L, Herman S, Yen-Lieberman B. Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment. J Clin Microbiol 2000; 38:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/31\">",
"      Garc&iacute;a-Bujalance S, Ladr&oacute;n de Guevara C, Gonz&aacute;lez-Garc&iacute;a J, et al. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1. J Microbiol Methods 2007; 69:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/32\">",
"      Griffith BP, Mayo DR. Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT). J Clin Virol 2006; 35:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/33\">",
"      Ginocchio CC, Kemper M, Stellrecht KA, Witt DJ. Multicenter evaluation of the performance characteristics of the NucliSens HIV-1 QT assay used for quantitation of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2003; 41:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/34\">",
"      Erice A, Brambilla D, Bremer J, et al. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2000; 38:2837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/35\">",
"      Sun R, Ku J, Jayakar H, et al. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998; 36:2964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/36\">",
"      Witt DJ, Kemper M, Stead A, et al. Relationship of incremental specimen volumes and enhanced detection of human immunodeficiency virus type 1 RNA with nucleic acid amplification technology. J Clin Microbiol 2000; 38:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/37\">",
"      Palumbo PE, Kwok S, Waters S, et al. Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr 1995; 126:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/38\">",
"      Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/39\">",
"      Schacker TW, Hughes JP, Shea T, et al. Biological and virologic characteristics of primary HIV infection. Ann Intern Med 1998; 128:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/40\">",
"      Holodniy M, Mole L, Winters M, Merigan TC. Diurnal and short-term stability of HIV virus load as measured by gene amplification. J Acquir Immune Defic Syndr 1994; 7:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/41\">",
"      Brambilla D, Reichelderfer PS, Bremer JW, et al. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program. AIDS 1999; 13:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/42\">",
"      Donovan RM, Bush CE, Markowitz NP, et al. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996; 174:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/43\">",
"      Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/44\">",
"      O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/45\">",
"      Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/46\">",
"      Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 1996; 275:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/47\">",
"      Cartwright CP. The changing epidemiology of HIV/AIDS at a Minnesota hospital: impact of demographic change and viral diversity. J Med Virol 2006; 78 Suppl 1:S19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/48\">",
"      Lin HH, Gaschen BK, Collie M, et al. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J Acquir Immune Defic Syndr 2006; 41:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/49\">",
"      Parekh B, Phillips S, Granade TC, et al. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999; 15:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/50\">",
"      Jagodzinski LL, Wiggins DL, McManis JL, et al. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol 2000; 38:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/51\">",
"      Swanson P, Huang S, Abravaya K, et al. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. J Virol Methods 2007; 141:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39623/abstract/52\">",
"      Rouet F, Chaix ML, Nerrienet E, et al. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr 2007; 45:380.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3743 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-641A5F4110-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39623=[""].join("\n");
var outline_f38_44_39623=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14118823\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14118660\">",
"      IMPORTANCE OF HIV VIRAL LOAD MEASUREMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LABORATORY METHODS FOR QUANTITATION OF HIV-1 RNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Specimen collection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Quantification and linear range",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnostic testing in adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnostic testing in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INTERPRETATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinically significant changes in viral load",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14118983\">",
"      Exogenous factors that may affect HIV RNA levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Relationship of HIV-1 RNA to CD4 cell count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HIV-1 subtypes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      GUIDELINES FOR THE USE OF HIV-1 RNA LEVELS IN CLINICAL PRACTICE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      AVAILABILITY AND COST OF VIRAL LOAD TESTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14118823\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22808?source=related_link\">",
"      Acute and early HIV infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=related_link\">",
"      Diagnostic assays for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/44/35525?source=related_link\">",
"      Diagnostic testing for HIV infection in infants and children younger than 18 months",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/52/21320?source=related_link\">",
"      Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/28/31175?source=related_link\">",
"      Transfusion transmitted HIV infection and AIDS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_44_39624="Diagnostic testing for syphilis";
var content_f38_44_39624=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic testing for syphilis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/44/39624/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/44/39624/contributors\">",
"     Charles B Hicks, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/44/39624/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/44/39624/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/44/39624/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/44/39624/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/44/39624/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syphilis is a sexually transmitted disease caused by the spirochete Treponema pallidum. The manifestations of disease are notoriously protean, with different stages occurring over time in untreated disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Patients may seek evaluation of symptoms or signs of primary infection (eg, chancre), secondary infection (eg, diffuse rash), or tertiary infection (eg, symptoms of aortic insufficiency). Alternatively, patients may be completely asymptomatic and only identified on routine screening.",
"   </p>",
"   <p>",
"    The diagnosis of syphilis is most commonly made by serologic testing, a technique first described by Wasserman in 1906 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/4\">",
"     4",
"    </a>",
"    ]. The appropriate use and interpretation of diagnostic testing is important for optimal patient management.",
"   </p>",
"   <p>",
"    Diagnostic testing for suspected syphilis will be reviewed here. Laboratory monitoring of patients undergoing therapy is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18837?source=see_link\">",
"     \"Laboratory monitoring of patients undergoing treatment for syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathophysiology, natural history, clinical manifestations, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/55/12150?source=see_link\">",
"     \"Pathophysiology, transmission, and natural history of syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of early syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of late syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TARGET GROUPS FOR TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing for syphilis is performed in the following scenarios:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suspected disease (eg, patient with a painless genital ulcer consistent with a syphilitic chancre)",
"     </li>",
"     <li>",
"      Screening of high-risk populations (eg, patients presenting to a STD clinic, inmates, persons with multiple sexual partners, men who have sex with men who engage in high-risk behaviors)",
"     </li>",
"     <li>",
"      Routine screening (eg, women attending antenatal or family planning clinics)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Serologic testing is also recommended by the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association at least annually for all sexually active HIV-infected patients; more frequent screening (every three to six months) is recommended for those with multiple sex partners, unprotected intercourse, sex in conjunction with illicit drug use, and methamphetamine use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rationale for screening for syphilis in asymptomatic patients is related to the natural history of the disease and to issues of public health. Although early stage syphilis will often resolve without treatment, untreated syphilis may progress to later stage disease, which can cause severe morbidity and which can be generally more difficult to treat. Furthermore, patients with unsuspected early primary or secondary disease can have lesions (eg, chancres and condyloma lata) that are teeming with spirochetes, making them highly infectious to others. Thus, it is important to screen for syphilis in certain high-risk patient populations. The United States Preventive Services Task Force (USPSTF) recommends screening men who have sex with men (MSM) who engage in high-risk behaviors, commercial sex workers, persons who exchange sex for drugs, and inmates in adult correctional facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/6\">",
"     6",
"    </a>",
"    ]. Screening for syphilis is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Screening in pregnant women is recommended to prevent in utero transmission of asymptomatic infection, which can lead to congenital syphilis. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/61/4057?source=see_link\">",
"     \"Syphilis in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTING METHODS",
"    </span>",
"    &nbsp;&mdash;&nbsp;T. pallidum cannot be cultured in the laboratory. Thus, syphilis must be identified by either direct visualization of the organism in clinical specimens, or, more commonly, by serology.",
"   </p>",
"   <p>",
"    Serologic testing traditionally involves a nonspecific nontreponemal antibody test followed by a more specific treponemal test for diagnostic confirmation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/5\">",
"     5",
"    </a>",
"    ]. The combination of a compatible clinical presentation plus reactive serologies for syphilis represents a presumptive clinical diagnosis (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Serologic tests'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Techniques to diagnose syphilis directly from clinical specimens include darkfield microscopy, direct fluorescent antibody (DFA) and investigational polymerase chain reaction (PCR) testing methods. Identification of T. pallidum by either darkfield microscopy or DFA represents a definitive diagnosis of syphilis (see below). These procedures provide definitive rather than presumptive diagnostic information, but are more labor intensive, and are infrequently used currently.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Serologic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is the mainstay of diagnosis of syphilis due to the complexities of direct visualization techniques. There are two types of serologic tests for syphilis: nontreponemal tests (that are traditionally used for primary screening) and specific treponemal tests (usually done to confirm infection). The use of only one test is insufficient for diagnosis since each test has diagnostic limitations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many laboratories have changed the sequence of testing, as discussed below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Testing algorithms'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Nontreponemal tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nontreponemal tests (also known as tests for reagin antibodies) are based upon the reactivity of serum, from patients with syphilis, to a cardiolipin-cholesterol-lecithin antigen. Although these screening tests are non-specific and therefore not definitive, they have traditionally been used for initial syphilis screening due to their relative low cost and ease of performance.",
"   </p>",
"   <p>",
"    Nontreponemal tests include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Venereal Disease Research Laboratory (VDRL)",
"     </li>",
"     <li>",
"      Rapid Plasma Reagin (RPR)",
"     </li>",
"     <li>",
"      Toludine Red Unheated Serum Test (TRUST)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, these assays are semi-quantitative in that the amount of antibody present (both IgM and IgG) generally reflects the activity of the infection. Positive nontreponemal tests are reported as a titer of antibody (eg, 1:32, which represents the detection of antibody in serum diluted 32-fold). Titers tend to wane over time even without treatment, but successful therapy accelerates the pace of antibody decline. Changes in titer are followed after treatment to detect a therapeutic response. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18837?source=see_link&amp;anchor=H11#H11\">",
"     \"Laboratory monitoring of patients undergoing treatment for syphilis\", section on 'Changes in titer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serologic testing is an indirect method of diagnosis since it relies upon a humoral immune response to infection. As such, it has some inherent limitations, particularly in the HIV-infected patient with advanced immunosuppression. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Diagnosis of syphilis in HIV-infected patients'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    False positive nontreponemal tests have also been associated with pregnancy, intravenous drug use, tuberculosis, rickettsial infection, non-syphilis treponemal infection, and endocarditis, among others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Consequently, a reactive nontreponemal test must always be confirmed with a specific treponemal test for proper interpretation. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Interpretation of serologic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Treponemal tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treponemal tests have historically been more complex and expensive to perform; they have traditionally been used as confirmatory tests for syphilis when the nontreponemal tests are reactive. Recent versions of these tests have been automated, enhancing simplicity and facilitating ease of use.",
"   </p>",
"   <p>",
"    Specific treponemal tests include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fluorescent treponemal antibody absorption (FTA-ABS)",
"     </li>",
"     <li>",
"      Microhemagglutination test for antibodies to Treponema pallidum (MHA-TP)",
"     </li>",
"     <li>",
"      Treponema pallidum particle agglutination assay (TP-PA)",
"     </li>",
"     <li>",
"      Treponema pallidum enzyme immunoassay (TP-EIA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a group, these tests are based upon the detection of antibodies directed against specific treponemal antigens and thus tend to be more specific than non-treponemal tests. Treponemal tests are qualitative only and are reported as \"reactive\" or \"nonreactive\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/11\">",
"     11",
"    </a>",
"    ]. EIA has become the favored method of confirmatory diagnosis in many laboratories, particularly those with large volumes of testing and increasingly have become the preferred screening test rather than using non-treponemal tests. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Nontraditional screening approaches'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Direct methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct identification of spirochetes can be accomplished either through darkfield microscopy or direct fluorescent antibody testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Darkfield microscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, the quickest and most direct method for diagnosing primary and secondary syphilis has been direct visualization of the spirochete from moist lesions (eg, mucous membranes) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/11\">",
"     11",
"    </a>",
"    ]. Darkfield microscopy enables demonstration of thin, delicate, corkscrew-shaped organisms with rigid, tightly wound spirals. A positive darkfield slide illustrates the characteristic motility associated with T. pallidum: a forward and backward motion with rotation about the longitudinal axis (",
"    <a class=\"graphic graphic_picture graphicRef56211 \" href=\"mobipreview.htm?27/58/28590\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/11\">",
"     11",
"    </a>",
"    ]. Soft side-to-side bending and twisting may also be seen.",
"   </p>",
"   <p>",
"    Failure to identify the organisms in a specimen does",
"    <strong>",
"     not",
"    </strong>",
"    exclude the diagnosis of primary syphilis. Optimal performance of darkfield microscopy starts with adequate collection of the specimen and its expeditious delivery to the microscopist who should be experienced in the identification of T. pallidum. Moreover, the proper equipment must be readily available so that the specimen can be examined promptly.",
"   </p>",
"   <p>",
"    In clinical practice, darkfield microscopy is generally limited to clinics that specialize in the diagnosis and treatment of sexually transmitted diseases (STDs). The specifics of specimen collection and the use of a darkfield microscope are described elsewhere [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Direct fluorescent antibody testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative method of identifying T. pallidum from lesions is direct fluorescent antibody testing (DFA-TP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/12\">",
"     12",
"    </a>",
"    ]. This technique has the advantage of permitting the identification of the organism when smears cannot be examined immediately. It also avoids the problem of misidentifying other miscellaneous spirochetes since it is specific for T. pallidum antigens.",
"   </p>",
"   <p>",
"    This test requires a fluorescence microscope and a trained and experienced technologist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/13\">",
"     13",
"    </a>",
"    ]. DFA-TP is not widely available in most STD clinics, but can be ordered from many state health departments. Air-dried specimens of lymph node aspirates, genital mucosal lesions, and chancres may be sent for evaluation; however, local requirements for specimen collection should be clarified prior to sending any specimens for DFA testing.",
"   </p>",
"   <p>",
"    The clinical performance of these tests is at least in part related to the population being tested; the greater the pretest probability that syphilis is present, the better the test performance. In general, test performance with fresh specimens results in the best sensitivity (approaching 100 percent for the DFA), but a negative test does not totally exclude the diagnosis of syphilis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Investigational techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular and serologic techniques to diagnose syphilis are being explored to improve turnaround times for testing and to enhance sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Rapid serologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been considerable interest in simple, rapid tests for T. pallidum infection; advantages include rapid diagnosis at the point of care (within 5 to 20 minutes) and low cost of testing (ie, $1 to $3 per test) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/16\">",
"     16",
"    </a>",
"    ]. Most of the assays that have been developed have been treponemal assays; such assays do not distinguish between active and treated syphilis since treponemal antibody tests are non-quantitative and are not used to assess response to treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several tests are available for rapid syphilis testing, but none have been approved by the Food and Drug Administration (FDA) for the diagnosis of syphilis. Immunochromatography-based point-of-care tests to diagnose early syphilis have been evaluated and found to have good sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/16,18-21\">",
"     16,18-21",
"    </a>",
"    ]. The advantages of these assays include use of blood from a finger stick and the availability of rapid results (15 to 20 minutes), which can be interpreted by non-laboratory personnel. Since these tests detect T. pallidum recombinant antigens, the results correlate closely with those from more traditional treponemal-specific tests. In a meta-analysis of 33 studies that compared point-of-care diagnostic tests for syphilis with a T. pallidum-specific reference standard, using serum samples, point-of-care tests had sensitivities ranging from 74 to 90 percent and specificities ranging from 94 to 99 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/22\">",
"     22",
"    </a>",
"    ]. When whole blood samples were used, sensitivities ranged from 74 to 86 percent and specificities ranged from 96 to 100 percent. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Polymerase chain reaction testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Investigational polymerase chain reaction (PCR) assays for T. pallidum, based on the detection of various DNA target sequences, have been evaluated using a variety of methods (eg, classical PCR, nested PCR, reverse-transcription PCR, and quantitative PCR). Compared to clinical diagnostic criteria (history, physical findings, results of serologic testing), the sensitivity of PCR testing in swab specimens of mucosal sites has ranged from approximately 70 to 95 percent with a specificity from 92 to 98 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. In a recent study, the concordance between a nested PCR assay and the physician&rsquo;s diagnosis was 82.6 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/25\">",
"     25",
"    </a>",
"    ]. Unfortunately, sensitivity tends to be much lower in blood specimens (approximately 24 to 32 percent).",
"   </p>",
"   <p>",
"    A multiplex polymerase chain reaction (M-PCR) assay has also been developed that can simultaneously detect Treponema pallidum, Hemophilus ducreyi (the etiologic agent of chancroid), and herpes simplex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/28/10696?source=see_link\">",
"     \"Chancroid\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TESTING ALGORITHMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Standard algorithms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard testing algorithms include screening with a nontreponemal test such as the RPR; a reactive specimen is then confirmed as a true positive with a treponemal test, such as the FTA-ABS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"     7",
"    </a>",
"    ]. Confirmational testing is necessary due to the potential for a false-positive screening test result [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/29\">",
"     29",
"    </a>",
"    ]. However, it is highly unlikely that any one patient will have false positive tests using both reagin and treponemal techniques. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Interpretation of serologic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    All persons who are diagnosed with syphilis should be offered HIV testing and counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Nontraditional screening approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2008, the CDC reported that four New York City laboratories had reversed the traditional order of screening and confirmatory tests for syphilis (ie, specific treponemal testing prior to non-specific treponemal testing) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/8\">",
"     8",
"    </a>",
"    ]. Since an automated treponemal test can be less expensive than an RPR test in high-volume laboratories, reversal of the traditional syphilis screening sequence was initiated principally for cost reasons. This approach has become increasingly popular in many laboratories, particularly those with relatively high volumes of syphilis testing.",
"   </p>",
"   <p>",
"    However, this change in diagnostic procedures resulted in test results that would not have been identified by the traditional testing algorithm. A reactive treponemal test result was followed by a nonreactive nontreponemal test result in 3 percent of 116,822 specimens. The significance of these paired testing results is unclear since this order of testing has not been employed clinically; as a result, such nontraditional testing algorithms can lead to confusion regarding patient management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Importantly, the positive predictive value (PPV) and negative predictive value (NPV) of treponemal EIA tests as screens for syphilis depend on the prevalence of syphilis in the population being screened. One study reported the overall seroprevalence of syphilis in the United States to be 0.71 percent, a frequency that indicates the negative predictive value of the treponemal EIA exceeds 98 percent. However, the positive predictive value in such a population may be as low as 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/17,30\">",
"     17,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CDC has published some suggestions for diagnostic management for clinicians who receive these discordant results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If there is a history of previously treated syphilis, the non-reactive nontreponemal test indicates that active infection is unlikely and no further treatment or testing is warranted.",
"     </li>",
"     <li>",
"      For persons without a history of treatment, the CDC recommends that a second, different treponemal test (preferably the Treponema pallidum-Particle agglutination assay [TP-PA]), should be performed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"       7",
"      </a>",
"      ]. If the TP-PA test is nonreactive, and the patient has no symptoms or behavioral risk to suggest syphilis, the clinician may decide that no further evaluation or treatment is indicated; this approach is supported by one prospective study of more than 21,000 patients undergoing syphilis screening in a low prevalence setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If the second treponemal test is reactive, clinicians should discuss the possibility of infection and offer treatment to patients who have not been previously treated. Such patients are unlikely to be infectious (unless history or physical examination suggests otherwise) and should be treated for late latent infection, even though they do not meet standard surveillance criteria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the CDC recommends further testing in these unclear scenarios, we prefer a more directed, patient-centered approach. First, a directed history (including symptoms and behavioral risks) and physical examination should be performed with attention to findings associated with syphilis. If a chancre or rash is found, a nontreponemal test should be repeated to assess for seroconversion, and appropriate treatment should be administered at the same patient encounter. The response to treatment should be monitored clinically and serologically.",
"   </p>",
"   <p>",
"    If no signs or symptoms of syphilis are found, we counsel patients regarding a possible diagnosis of late latent syphilis and offer the opportunity to do further diagnostic testing. If a repeat treponemal test is negative we do not suggest any further evaluation. If the repeat treponemal test is positive, we recommend treatment for late latent syphilis. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Interpretation of serologic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    It should be noted that the recommendations from the CDC may not be appropriate outside of the US where the epidemiology of disease may be different. Additional analyses will be required to determine the total cost implications of these alternative screening methods. Given concerns regarding health care costs, the use of nontraditional screening methods may increase in the future.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INTERPRETATION OF SEROLOGIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper interpretation of syphilis testing is critical for appropriate patient management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Definitive diagnosis of syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;When both nontreponemal and treponemal tests are reactive, persons should be considered to have active syphilis, unless this is ruled out by prior treatment history.",
"   </p>",
"   <p>",
"    Symptomatic persons can be staged as having primary, secondary, or tertiary syphilis depending on their clinical manifestations. Asymptomatic persons with reactive nontreponemal and treponemal serologies are diagnosed with \"latent\" syphilis. The diagnosis of neurosyphilis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of early syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of late syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/44/26312?source=see_link\">",
"     \"Neurosyphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Patients with a history of treated syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In persons who were treated in the past, newly acquired syphilis infection is diagnosed if quantitative testing on an RPR test (or another nontreponemal test) reveals a fourfold or greater increase in titer. The prior baseline titer can often be determined by calling the local public health department, which maintains a registry of past positive tests. When possible, all titers should be compared using the same test methodology.",
"   </p>",
"   <p>",
"    Titers of nontreponemal assays decline following successful therapy and serologic testing usually revert to nonreactive over time; however, some patients may remain \"serofast\"; these patients may have reactive nontreponemal tests, but at low titer (eg, 1:2), despite successful treatment.",
"   </p>",
"   <p>",
"    Specific treponemal tests may remain positive for an extended period (eg, years) in many patients, despite adequate treatment and clinical response. Thus, a reactive treponemal test in a person with a history of treated syphilis should not be used alone to diagnose newly acquired syphilis.",
"   </p>",
"   <p>",
"    Serologic monitoring of the patient with syphilis following treatment is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18837?source=see_link\">",
"     \"Laboratory monitoring of patients undergoing treatment for syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     False positive test results",
"    </span>",
"    &nbsp;&mdash;&nbsp;False positive tests for syphilis (sometimes referred to as \"biologic false positive tests\") can occur with both nontreponemal and treponemal tests. A false positive test result may be identified by a reactive nontreponemal test followed by a non-reactive treponemal test. It is estimated that 1 to 2 percent of the United States population has false positive nontreponemal test results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/11\">",
"     11",
"    </a>",
"    ]. False positive tests are particularly common during pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/61/4057?source=see_link\">",
"     \"Syphilis in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some false positive nontreponemal test results are transitory and are related to an acute event, such as an acute febrile illness (eg, endocarditis, rickettsial disease) or recent immunization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/9\">",
"     9",
"    </a>",
"    ]. Test abnormalities attributed to these conditions typically last for six months or less.",
"   </p>",
"   <p>",
"    Other etiologies for false positive results of nontreponemal testing include a variety of chronic conditions, such as autoimmune disorders (particularly systemic lupus erythematosus), intravenous drug use, chronic liver disease, and perhaps underlying HIV disease.",
"   </p>",
"   <p>",
"    These false positive test results tend to be of low titer, but this is not always true, especially in HIV-infected patients; thus, the level of the titer alone does not reliably help the clinician differentiate between a true or false positive result. It is very important that each reactive nontreponemal test be followed with specific treponemal testing to determine if the result may be a false positive test or indicative of active syphilis. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Diagnosis of syphilis in HIV-infected patients'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     False negative test results",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensitivity of nontreponemal testing increases with the duration of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/32\">",
"     32",
"    </a>",
"    ]. A false negative syphilis test result may be identified by a nonreactive nontreponemal test in a patient with clinical signs or symptoms consistent with syphilis (eg, painless chancre). Further testing, based on clinical suspicion, can lead to a reactive specific treponemal test result. This type of testing pattern can be seen with very early infection (before serum antibodies have developed) or in a patient with a \"prozone reaction\".",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Testing prior to antibody formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Probably the most common cause of a false negative nontreponemal result is performance of the test prior to the development of humoral antibodies (",
"    <a class=\"graphic graphic_figure graphicRef54477 \" href=\"mobipreview.htm?43/26/44448\">",
"     figure 1",
"    </a>",
"    ). For example, 20 to 30 percent of patients presenting with a chancre will not have a reactive serologic test for syphilis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/32\">",
"     32",
"    </a>",
"    ]. In this setting, testing for treponemal antibodies is usually also nonreactive. If clinical suspicion is high, repeat serologic testing is indicated at a later time point (eg, one to two weeks later). If darkfield microscopy is available, scrapings of the lesion may be diagnostic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Prozone reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;A second major cause of a false negative test result is the \"prozone reaction\". This phenomenon occurs in less than 2 percent of samples from patients with syphilis.",
"   </p>",
"   <p>",
"    The prozone reaction refers to nonvisualization of agglutination, which normally occurs when antigen and antibody bind together to form a complex. When antibody titers are high (as in secondary syphilis), an overabundance of antibodies interferes with clumping of antigen-antibody complexes.",
"   </p>",
"   <p>",
"    Experienced laboratory technologists may suspect the prozone phenomenon when an apparent nonreactive test exhibits a rough or granular appearance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/6\">",
"     6",
"    </a>",
"    ]. When such a specimen is diluted, sufficient agglutination can be seen and the true sample reactivity becomes apparent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Early treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient with a history of early treatment intervention may have no laboratory evidence of prior syphilis because of full seroreversion in both nontreponemal and treponemal serologies. However, this is uncommonly seen.",
"   </p>",
"   <p>",
"    Finally, the natural history of a true positive screening test is usually to become nonreactive over time, even without treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF SYPHILIS IN HIV-INFECTED PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the HIV-infected patient with syphilis, the approach to diagnosis is generally made in the same way as for HIV-uninfected persons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/33\">",
"     33",
"    </a>",
"    ]. However, some caveats regarding the HIV-infected patient with advanced AIDS are important to note. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Diagnosis in patients with untreated AIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the era of potent antiretroviral therapy (ART), the accuracy of diagnostic testing was less clear in patients with advanced HIV infection. These observations may be applicable to the newly diagnosed patient with HIV infection who presents with symptoms or signs of syphilis, particularly those with low CD4 counts.",
"   </p>",
"   <p>",
"    In a 1991 study of 341 patients with syphilis, the geometric mean rapid plasma reagin titers were significantly higher in HIV-infected patients, although the clinical stage of syphilis at presentation did not differ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, HIV-infected individuals had a greater incidence of falsely reactive nontreponemal tests than those without HIV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. In two series of HIV-infected patients, for example, the rate of false positive tests was higher than controls for both the VDRL (6.8 versus 0.2 percent) and the RPR test (11 versus 0.8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Overall, however, nontreponemal screening was accurate in the vast majority of patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16712?source=see_link\">",
"     \"Screening laboratory tests in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, in patients with advanced immunosuppression, false negative testing for syphilis can be seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. This variability is thought to reflect abnormally active B-cell function during early HIV infection and B-cell failure during late-stage HIV infection.",
"   </p>",
"   <p>",
"    If serologic tests do not confirm the presence of syphilis in clinically suspected cases, other diagnostic procedures should be considered, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Repeat serology after one to two weeks to determine late seroconversion",
"     </li>",
"     <li>",
"      Biopsy of lesion for evidence of spirochetes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Discussion with laboratory personnel about possible prozone phenomena",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTING FOR NEUROSYPHILIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of cerebrospinal fluid is the only way to diagnose asymptomatic neurosyphilis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/39\">",
"     39",
"    </a>",
"    ]. A positive CSF VDRL is considered highly specific for neurosyphilis, but sensitivity is poor; only about 50 percent of patients with neurosyphilis have a positive CSF VDRL. Elevations of white blood cells and protein are non-specific, especially in HIV-infected patients. Thus, the laboratory diagnosis of neurosyphilis usually depends on various combinations of reactive serologic test results, CSF cell count and protein, and a reactive CSF-VDRL with or without clinical manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the CSF-VDRL is nonreactive, and neurosyphilis is suspected, a CSF FTA-ABS (Fluorescent treponemal antibody absorption (FTA-ABS)) can be ordered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"     7",
"    </a>",
"    ]. Although it is less specific than a CSF-VDRL, the CSF FTA-ABS test is highly sensitive; neurosyphilis is highly unlikely with a negative CSF FTA-ABS test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic approach to neurosyphilis is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/44/26312?source=see_link\">",
"     \"Neurosyphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     HIV-seronegative patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;T. pallidum disseminates widely after initial infection, and examination of the cerebrospinal fluid (CSF) during primary and secondary syphilis reveals a high incidence of central nervous system involvement. The identification of asymptomatic neurosyphilis is important for the proper management of persons with reactive syphilis serologies. Details of the approach to the diagnosis and management of neurosyphilis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/44/26312?source=see_link\">",
"     \"Neurosyphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     HIV-seropositive patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;In HIV-infected patients, the presence of a serum RPR &ge;1:32 or a CD4 count &lt;350",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    were both associated with an increased risk of neurosyphilis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/40\">",
"     40",
"    </a>",
"    ]. The diagnosis of neurosyphilis in the HIV-infected patient is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF REINFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of reinfection versus continued infection due to treatment failure can be difficult if a patient is lost to follow-up without intervening monitoring. One study suggested that reinfection is suggested by the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/44/39624/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior history of an appropriate treatment regimen",
"     </li>",
"     <li>",
"      Clinical manifestations of either primary or secondary syphilis",
"     </li>",
"     <li>",
"      History of new risk factor(s)",
"     </li>",
"     <li>",
"      A fourfold decline in RPR titers after retreatment (for example, a decline in titer from 1:64 to 1:16)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/61/10195?source=see_link\">",
"       \"Patient information: Syphilis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Syphilis is a chronic infection caused by the spirochete Treponema pallidum. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serologic testing is the mainstay of diagnosis of syphilis due to the complexities of direct visualization techniques and lack of culture techniques for T. pallidum. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnostic testing methods'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Persons considered at \"high risk\" for syphilis include men who have sex with men, inmates, persons with multiple sexual partners, patients with another sexually transmitted disease, and sexually active HIV-infected patients. We recommend screening for syphilis in patients considered at high risk (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Target groups for testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Syphilis testing is also routinely performed during pregnancy to prevent transmission of infection from an asymptomatic mother to her infant. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/61/4057?source=see_link\">",
"       \"Syphilis in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nontreponemal assays are semi-quantitative and are reported as a titer of antibody. The height of the antibody titer generally reflects the activity of disease; titers decline following appropriate treatment. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Nontreponemal tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast, treponemal tests are either reactive or nonreactive; once positive due to syphilitic infection, they tend to remain positive for an extended period in most patients. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treponemal tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Historically, the standard testing algorithm has been to perform initial screening with a nontreponemal test (eg, a VDRL test) and to confirm any reactive non-treponemal test with a treponemal-specific test (eg, a FTA-ABS test). Increasingly, this order has been reversed in clinical laboratories at least in part to achieve cost savings. Syphilis screening is now frequently done with a treponemal-specific ELISA and positive tests are followed by the quantitative non-treponemal test. This can create some degree of diagnostic confusion. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Testing algorithms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      False positive nontreponemal tests can be due to acute illness (eg, endocarditis) or due to chronic diseases (eg, autoimmune disorders). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Interpretation of serologic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to the diagnosis of syphilis in the HIV-infected patient is similar to the HIV-seronegative patient. The limitations of serologic testing must be considered in the patient with clinically suspected disease, nonreactive testing, and advanced immunosuppression. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Diagnosis of syphilis in HIV-infected patients'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/1\">",
"      Hook EW 3rd, Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/2\">",
"      Zetola NM, Engelman J, Jensen TP, Klausner JD. Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin Proc 2007; 82:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/3\">",
"      Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA 2003; 290:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/4\">",
"      Wassermann A, et al. Eine serodiagnostische reaktion bei syphilis. Dtsch Med Wochenschr 1906; 32:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/5\">",
"      Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/6\">",
"      Calonge N, U.S. Preventive Services Task Force. Screening for syphilis infection: recommendation statement. Ann Fam Med 2004; 2:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/7\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/8\">",
"      Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008; 57:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/9\">",
"      Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/10\">",
"      Hern&aacute;ndez-Aguado I, Bolumar F, Moreno R, et al. False-positive tests for syphilis associated with human immunodeficiency virus and hepatitis B virus infection among intravenous drug abusers. Valencian Study Group on HIV Epidemiology. Eur J Clin Microbiol Infect Dis 1998; 17:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/11\">",
"      Larsen SA. Syphilis. Clin Lab Med 1989; 9:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/12\">",
"      Hunter EF, Greer PW, Swisher BL, et al. Immunofluorescent staining of Treponema in tissues fixed with formalin. Arch Pathol Lab Med 1984; 108:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/13\">",
"      Chen CY, Chi KH, George RW, et al. Diagnosis of gastric syphilis by direct immunofluorescence staining and real-time PCR testing. J Clin Microbiol 2006; 44:3452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/14\">",
"      Zoechling N, Schluepen EM, Soyer HP, et al. Molecular detection of Treponema pallidum in secondary and tertiary syphilis. Br J Dermatol 1997; 136:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/15\">",
"      Centurion-Lara A, Castro C, Shaffer JM, et al. Detection of Treponema pallidum by a sensitive reverse transcriptase PCR. J Clin Microbiol 1997; 35:1348.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization: The sexually transmitted diagnostics initiative (SDI): special programme for research and training in tropical diseases (TDR), Geneva: World Health Organization, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/17\">",
"      Se&ntilde;a AC, White BL, Sparling PF. Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 2010; 51:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/18\">",
"      Zarakolu P, Buchanan I, Tam M, et al. Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies. J Clin Microbiol 2002; 40:3064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/19\">",
"      Herring AJ, Ballard RC, Pope V, et al. A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect 2006; 82 Suppl 5:v7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/20\">",
"      Castro AR, Esfandiari J, Kumar S, et al. Novel point-of-care test for simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis. J Clin Microbiol 2010; 48:4615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/21\">",
"      Yin YP, Chen XS, Wei WH, et al. A dual point-of-care test shows good performance in simultaneously detecting nontreponemal and treponemal antibodies in patients with syphilis: a multisite evaluation study in China. Clin Infect Dis 2013; 56:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/22\">",
"      Jafari Y, Peeling RW, Shivkumar S, et al. Are Treponema pallidum Specific Rapid and Point-of-Care Tests for Syphilis Accurate Enough for Screening in Resource Limited Settings? Evidence from a Meta-Analysis. PLoS One 2013; 8:e54695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/23\">",
"      Liu H, Rodes B, Chen CY, Steiner B. New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase I gene. J Clin Microbiol 2001; 39:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/24\">",
"      Leslie DE, Azzato F, Karapanagiotidis T, et al. Development of a real-time PCR assay to detect Treponema pallidum in clinical specimens and assessment of the assay's performance by comparison with serological testing. J Clin Microbiol 2007; 45:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/25\">",
"      Grange PA, Gressier L, Dion PL, et al. Evaluation of a PCR test for detection of treponema pallidum in swabs and blood. J Clin Microbiol 2012; 50:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/26\">",
"      Beyrer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis 1998; 178:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/27\">",
"      Morse SA, Trees DL, Htun Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997; 175:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/28\">",
"      Orle KA, Gates CA, Martin DH, et al. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol 1996; 34:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/29\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/30\">",
"      Gottlieb SL, Pope V, Sternberg MR, et al. Prevalence of syphilis seroreactivity in the United States: data from the National Health and Nutrition Examination Surveys (NHANES) 2001-2004. Sex Transm Dis 2008; 35:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/31\">",
"      Park IU, Chow JM, Bolan G, et al. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/32\">",
"      Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986; 104:368.",
"     </a>",
"    </li>",
"    <li>",
"     DHHS panel on guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents, June 18, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/34\">",
"      Hutchinson CM, Rompalo AM, Reichart CA, Hook EW 3rd. Characteristics of patients with syphilis attending Baltimore STD clinics. Multiple high-risk subgroups and interactions with human immunodeficiency virus infection. Arch Intern Med 1991; 151:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/35\">",
"      Rompalo AM, Cannon RO, Quinn TC, Hook EW 3rd. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis 1992; 165:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/36\">",
"      Augenbraun MH, DeHovitz JA, Feldman J, et al. Biological false-positive syphilis test results for women infected with human immunodeficiency virus. Clin Infect Dis 1994; 19:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/37\">",
"      Hicks CB, Benson PM, Lupton GP, Tramont EC. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med 1987; 107:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/38\">",
"      Tikj&oslash;b G, Russel M, Petersen CS, et al. Seronegative secondary syphilis in a patient with AIDS: identification of Treponema pallidum in biopsy specimen. J Am Acad Dermatol 1991; 24:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/39\">",
"      Sparling PF. Diagnosis of neurosyphilis: New tools. Sex Transm Dis 2010; 37:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/40\">",
"      Ghanem KG, Moore RD, Rompalo AM, et al. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009; 48:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/44/39624/abstract/41\">",
"      Ogilvie GS, Taylor DL, Moniruzzaman A, et al. A population-based study of infectious syphilis rediagnosis in British Columbia, 1995-2005. Clin Infect Dis 2009; 48:1554.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7588 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-9C20EB8C63-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39624=[""].join("\n");
var outline_f38_44_39624=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TARGET GROUPS FOR TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSTIC TESTING METHODS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Serologic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Nontreponemal tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Treponemal tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Direct methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Darkfield microscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Direct fluorescent antibody testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Investigational techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Rapid serologic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Polymerase chain reaction testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TESTING ALGORITHMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Standard algorithms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Nontraditional screening approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INTERPRETATION OF SEROLOGIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Definitive diagnosis of syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Patients with a history of treated syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      False positive test results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      False negative test results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Testing prior to antibody formation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Prozone reaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Early treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      DIAGNOSIS OF SYPHILIS IN HIV-INFECTED PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Diagnosis in patients with untreated AIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      DIAGNOSTIC TESTING FOR NEUROSYPHILIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      HIV-seronegative patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      HIV-seropositive patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      DIAGNOSIS OF REINFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7588\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7588|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/26/44448\" title=\"figure 1\">",
"      Antibody development syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7588|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/58/28590\" title=\"picture 1\">",
"      Darkfield Treponema pallidum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/28/10696?source=related_link\">",
"      Chancroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3865?source=related_link\">",
"      Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18837?source=related_link\">",
"      Laboratory monitoring of patients undergoing treatment for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/44/26312?source=related_link\">",
"      Neurosyphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of early syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of late syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/55/12150?source=related_link\">",
"      Pathophysiology, transmission, and natural history of syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/61/10195?source=related_link\">",
"      Patient information: Syphilis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16712?source=related_link\">",
"      Screening laboratory tests in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/61/4057?source=related_link\">",
"      Syphilis in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_44_39625="Purpura fulminans";
var content_f38_44_39625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53920%7EDERM%2F61719%7EDERM%2F65011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53920%7EDERM%2F61719%7EDERM%2F65011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Purpura fulminans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sharply demarcated purpuric lesions were present in this patient with purpura fulminans.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Retiform purpura in disseminated intravascular coagulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread retiform purpura are present in this patient with disseminated intravascular coagulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Purpura in antiphospholipid antibody syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 395px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retiform purpura are present on the buttock.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39625=[""].join("\n");
var outline_f38_44_39625=null;
var title_f38_44_39626="Porokeratosis histopathology 2";
var content_f38_44_39626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61211%7EDERM%2F67831%7EDERM%2F66289&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61211%7EDERM%2F67831%7EDERM%2F66289&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Histopathology of porokeratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A thin vertical column of parakeratosis, known as a cornoid lamella, is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Porokeratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 491px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A column of parakeratosis consistent with a cornoid lamella is present in the center of this specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histopathology of porokeratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A column of parakeratotic cells consistent with a cornoid lamella is present within the dermis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39626=[""].join("\n");
var outline_f38_44_39626=null;
var title_f38_44_39627="One-day schedule for aeroallergen SCIT";
var content_f38_44_39627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F81687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F81687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Aeroallergen SCIT &ndash; One day",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Time (min)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume (ml)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dilution",
"       </td>",
"       <td class=\"subtitle1\">",
"        Color vial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        1:1000",
"       </td>",
"       <td>",
"        Green",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        0.10",
"       </td>",
"       <td>",
"        1:100",
"       </td>",
"       <td>",
"        Blue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        1:100",
"       </td>",
"       <td>",
"        Blue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"       <td>",
"        1:10",
"       </td>",
"       <td>",
"        Yellow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        120",
"       </td>",
"       <td>",
"        0.15",
"       </td>",
"       <td>",
"        1:10",
"       </td>",
"       <td>",
"        Yellow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        180",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        1:10",
"       </td>",
"       <td>",
"        Yellow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        240",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"       <td>",
"        1:1",
"       </td>",
"       <td>",
"        Red",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        300",
"       </td>",
"       <td>",
"        0.10",
"       </td>",
"       <td>",
"        1:1",
"       </td>",
"       <td>",
"        Red",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Sharkey, P, Portnoy, J. Rush immunotherapy: experience with a one-day schedule. Ann Allergy Asthma Immunol 1996; 76:175.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39627=[""].join("\n");
var outline_f38_44_39627=null;
var title_f38_44_39628="Causes acute hip pain children";
var content_f38_44_39628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of acute hip pain in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Infectious",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Septic arthritis of the hip",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Septic arthritis of the sacroiliac joint",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lyme disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Osteomyelitis of femoral head or pelvis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Psoas abscess",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Appendicitis or abdominal/pelvic abscess",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Inflammatory",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Transient synovitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Systemic arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            - Spondyloarthropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            - Juvenile idiopathic arthritis (formerly juvenile rheumatoid arthritis) (rare as isolated hip pain)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            - Kawasaki disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            - Infectious/post-infectious",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Idiopathic chondrolysis of the hip",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic recurrent multifocal osteomyelitis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Mechanical/orthopedic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Slipped capital femoral epiphysis (SCFE)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Avascular necrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            - Legg-Calv&eacute;-Perthes disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            - Secondary avascular necrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Femoral stress fracture",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Muscular strain",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neoplastic/infiltrative",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Osteoid osteoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leukemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Solid tumor, primary or metastatic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pigmented villonodular synovitis (PVNS)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Other",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sickle cell pain crisis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39628=[""].join("\n");
var outline_f38_44_39628=null;
var title_f38_44_39629="Neurodevelopmental outcome of extremely premature survivors";
var content_f38_44_39629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rates of neurodevelopmental outcomes among survivors in selected studies for infants 22 to 25 weeks gestation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Outcome",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"5\">",
"        Rate (percent) by gestational week",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Comment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        22",
"       </td>",
"       <td class=\"subtitle2\">",
"        23",
"       </td>",
"       <td class=\"subtitle2\">",
"        24",
"       </td>",
"       <td class=\"subtitle2\">",
"        25",
"       </td>",
"       <td class=\"subtitle2\">",
"        Total",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        EPICure",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        CP",
"       </td>",
"       <td class=\"centered\">",
"        n/a",
"       </td>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td class=\"centered\">",
"        21",
"       </td>",
"       <td class=\"centered\">",
"        20",
"       </td>",
"       <td class=\"centered\">",
"        20",
"       </td>",
"       <td>",
"        As defined by European Surveillance of CP Network at 2 y",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cognitive score &lt;70",
"       </td>",
"       <td class=\"centered\">",
"        n/a",
"       </td>",
"       <td class=\"centered\">",
"        11",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td>",
"        K-ABC test at 5 to 6 y in 64 percent of children without severe disability",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Epipage",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        CP",
"       </td>",
"       <td class=\"centered\">",
"        n/a",
"       </td>",
"       <td class=\"centered\">",
"        33",
"       </td>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td class=\"centered\">",
"        16.3",
"       </td>",
"       <td class=\"centered\">",
"        16",
"       </td>",
"       <td>",
"        As defined by European Surveillance of CP Network at 2 y",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cognitive score &lt;70",
"       </td>",
"       <td class=\"centered\">",
"        n/a",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        23",
"       </td>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td>",
"        K-ABC test at 5 to 6 y in 57 percent of children without severe disability",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Tyson",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        Impairment",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        65",
"       </td>",
"       <td class=\"centered\">",
"        50",
"       </td>",
"       <td class=\"centered\">",
"        36",
"       </td>",
"       <td class=\"centered\">",
"        47",
"       </td>",
"       <td>",
"        MDI or PDI &lt;70, moderate or severe CP, blindness, or bilateral hearing loss requiring amplification at 18 to 22 mos corrected age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Profound impairment",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        38",
"       </td>",
"       <td class=\"centered\">",
"        23",
"       </td>",
"       <td class=\"centered\">",
"        17",
"       </td>",
"       <td class=\"centered\">",
"        24",
"       </td>",
"       <td>",
"        MDI or PDI &lt;50 or severe gross motor deficit requiring adult assistance to move at 18 to 22 mos corrected age",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\" rowspan=\"6\">",
"        Carlo",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"       <td class=\"sublist1_start\" colspan=\"6\">",
"        Impairment",
"       </td>",
"       <td class=\"sublist1_start\" rowspan=\"3\">",
"        MDI or PDI &le;70, moderate or severe CP, blindness, or bilateral hearing loss requiring amplification at 18-22 mos corrected age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ANS",
"       </td>",
"       <td class=\"centered\">",
"        59",
"       </td>",
"       <td class=\"centered\">",
"        55",
"       </td>",
"       <td class=\"centered\">",
"        42",
"       </td>",
"       <td class=\"centered\">",
"        34",
"       </td>",
"       <td class=\"centered\">",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        No ANS",
"       </td>",
"       <td class=\"centered\">",
"        56",
"       </td>",
"       <td class=\"centered\">",
"        56",
"       </td>",
"       <td class=\"centered\">",
"        52",
"       </td>",
"       <td class=\"centered\">",
"        44",
"       </td>",
"       <td class=\"centered\">",
"        49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"6\">",
"        CP",
"       </td>",
"       <td class=\"sublist1_start\" rowspan=\"3\">",
"        Moderate or severe CP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ANS",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        11",
"       </td>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        No ANS",
"       </td>",
"       <td class=\"centered\">",
"        16",
"       </td>",
"       <td class=\"centered\">",
"        19",
"       </td>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CP: cerebral palsy; n/a: not available; K-ABC test: Mental Processing Composite of the Kaufman Assessment Battery for Children; MDI: Mental Developmental Index of the Bayley Scales of Infant Development-II; PDI: Psychomotor Developmental Index of the Bayley Scales of Infant Development-II; y: year; mos: months; ANS: antenatal steroid therapy.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Costeloe K, Hennessy E, Gibson AT, et al. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000; 106:659.",
"      </li>",
"      <li>",
"       Larroque B, Br&eacute;art G, Kaminski M, et al. Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child Fetal Neonatal Ed 2004; 89:F139.",
"      </li>",
"      <li>",
"       Tyson JE, Parikh NA, Langer J, et al. Intensive care for extreme prematurity--moving beyond gestational age. N Engl J Med 2008; 358:1672.",
"      </li>",
"      <li>",
"       Carlo WA, McDonald SA, Fanaroff AA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA 2011; 306:2348.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39629=[""].join("\n");
var outline_f38_44_39629=null;
var title_f38_44_39630="Inguinal swelling in a girl";
var content_f38_44_39630=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 656px\">",
"   <div class=\"ttl\">",
"    Inguinal swelling in a girl",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 636px; height: 357px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Ultrasound should be performed.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39630=[""].join("\n");
var outline_f38_44_39630=null;
var title_f38_44_39631="Papular PKDL";
var content_f38_44_39631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Patient with papular PKDL",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Papular PKDL in a 14 year old boy in Bihar, India. He had already been treated with more than 60 injections of sodium stibogluconate with only partial resolution of his rash.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Caryn Bern, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_44_39631=[""].join("\n");
var outline_f38_44_39631=null;
